Boosting Bioavailability: How Companies Are Using Advanced Technologies To Formulate Complex Molecules

Oral dosage forms have remained a cornerstone of drug development despite the proliferation of alternative dosage forms to address unmet medical needs. The continued relevance of the format is underpinned by technologies that have helped overcome bioavailability challenges and enabled the formulation of more complex molecules.

To better understand the landscape today, Catalent and a partner asked 200+ people involved in the oral dose market from April to May 2020 for their views on barriers to the development of oral formulations and technological responses to them.